Australasian Journal of Dermatology最新文献

筛选
英文 中文
Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review. 新出现的特比萘芬耐药毛癣皮癣,测试选择和替代治疗:系统综述。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-24 DOI: 10.1111/ajd.14575
Thuvarahan Jegathees, Zachary P Holmes, Catherine Martin, Cindy Kalai, Catherine Voutier, Denis Spelman, Gemma Robertson, Johannes S Kern
{"title":"Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review.","authors":"Thuvarahan Jegathees, Zachary P Holmes, Catherine Martin, Cindy Kalai, Catherine Voutier, Denis Spelman, Gemma Robertson, Johannes S Kern","doi":"10.1111/ajd.14575","DOIUrl":"https://doi.org/10.1111/ajd.14575","url":null,"abstract":"<p><p>Dermatophytosis is a common superficial fungal infection of the skin, most often caused by dermatophytes from the Trichophyton genus. Terbinafine, which inhibits squalene epoxidase (SQLE), is widely used as first line treatment. However, resistance to terbinafine is increasing globally, including recent reports in Australia, with origins suspected to trace back to South Asia. Antifungal susceptibility testing is not routinely available in Australia, and globally, there are no standardised breakpoints for traditional culture-based methods. Although SQLE gene mutations have been associated with terbinafine resistance, a major research gap exists in the clinical interpretation of these mutations due to a lack of correlation between MIC values, genetic mutations and clinical treatment outcomes. This gap hampers the ability to guide clinical decision-making. Therefore, our objective was to assess the global prevalence of terbinafine-resistant Trichophyton infections, identify the most clinically relevant resistance testing methods, and determine effective alternative treatment options. The study was designed by systematic review. Ovid MEDLINE, Ovid Embase, Cochrane Database of Systematic Reviews (CDSR), Cochrane's Trials database (CENTRAL), Global Health (CABI), Trials registries, along with Google Scholar and Web of Science (WoS) for the tracking of included articles. Published human studies in English from 2000 to 2023 of Terbinafine-resistant Trichophyton Dermatophytosis with confirmed antifungal susceptibility tests and genotyping of dermatophytes, as well as details of effective alternative treatments. Identified cases were independently screened by two authors on the basis of predetermined criteria. Thirty four studies reported 743 samples for which mutation data of the SQLE gene and minimum inhibitory concentration (MIC) were available. Twenty three studies reported on 149 patients who had used terbinafine with available MIC data. Of these, 94 cases demonstrated evidence of clinical resistance to terbinafine with confirmed SQLE genotyping and MIC data. Seven studies reported on 13 cases of clinical resistance to terbinafine with a reported MIC and a successful alternative therapy. There are no published MIC breakpoints for terbinafine resistance in antifungal resistance testing, creating significant challenges for clinical interpretation. This study suggests that an estimate of a provisional MIC threshold for resistance is calculated to be 1.69 μg/mL. Importantly, SQLE mutation data, particularly the presence of F397L, L393F and A448T shows a robust association with clinical resistance to terbinafine (odds ratio: 7.58; 14.0, 7.78, respectively). Routine SQLE mutation testing in cases of suspected terbinafine-resistant dermatophytosis could enhance diagnostic accuracy and inform more effective, timely treatment decisions. Identifying specific mutations may guide clinicians in selecting alternative antifungal agents earlier in the treatment","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144697503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia. 告知在澳大利亚皮肤科使用大型语言模型和AI抄写员的立场声明。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-18 DOI: 10.1111/ajd.14566
Liam J Caffery, Monica L Taylor, Lisa M Abbott, Monika Janda, Pascale Guitera, Victoria Mar, Chris Arnold, Stephen Shumack, Tony Caccetta, Robert Miller, H Peter Soyer
{"title":"Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia.","authors":"Liam J Caffery, Monica L Taylor, Lisa M Abbott, Monika Janda, Pascale Guitera, Victoria Mar, Chris Arnold, Stephen Shumack, Tony Caccetta, Robert Miller, H Peter Soyer","doi":"10.1111/ajd.14566","DOIUrl":"https://doi.org/10.1111/ajd.14566","url":null,"abstract":"<p><p>Artificial Intelligence (AI) refers to the ability of computers to mimic human intelligence. In response to the growing interest and impact of AI, the Australasian College of Dermatologists released its first Position Statement on AI in dermatology in 2022. This Position Statement provided guidance for dermatologists on the appropriate use of AI. Since then, the AI landscape has evolved substantially, particularly with the emergence of Large Language Models (LLMs). This article explores key developments in AI driven by LLMs, including the increasing use of AI scribes, and provides updated guidance for dermatologists in Australia.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144658243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recalcitrant Erythema Multiforme Minor Successfully Treated With Apremilast-A Novel Insight. 用apremilast成功治疗顽固性轻微多形性红斑——一个新发现。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-16 DOI: 10.1111/ajd.14564
Carmen Cánovas Seva, Lorena Martínez Leboráns, Carlos Aliste Santos, Jose Manuel Suárez Peñaranda, Ángeles Flórez
{"title":"Recalcitrant Erythema Multiforme Minor Successfully Treated With Apremilast-A Novel Insight.","authors":"Carmen Cánovas Seva, Lorena Martínez Leboráns, Carlos Aliste Santos, Jose Manuel Suárez Peñaranda, Ángeles Flórez","doi":"10.1111/ajd.14564","DOIUrl":"https://doi.org/10.1111/ajd.14564","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter by Wallace et al. 对Wallace等人来信的回应。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-16 DOI: 10.1111/ajd.14568
Samantha Ting, Patricia Lowe, Pablo Fernández-Peñas
{"title":"Response to Letter by Wallace et al.","authors":"Samantha Ting, Patricia Lowe, Pablo Fernández-Peñas","doi":"10.1111/ajd.14568","DOIUrl":"https://doi.org/10.1111/ajd.14568","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Spontaneous Generalised Keloids With Dupilumab: A Case Report. 杜匹单抗成功治疗自发性广泛性瘢痕疙瘩1例。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-16 DOI: 10.1111/ajd.14572
Lachlan D W Lau, Nicholas Manuelpillai, Holly Sexton, Laura Scardamaglia
{"title":"Successful Treatment of Spontaneous Generalised Keloids With Dupilumab: A Case Report.","authors":"Lachlan D W Lau, Nicholas Manuelpillai, Holly Sexton, Laura Scardamaglia","doi":"10.1111/ajd.14572","DOIUrl":"https://doi.org/10.1111/ajd.14572","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lichen Planus Follicularis Tumidus.
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-07 DOI: 10.1111/ajd.14545
A I Oloruntoba, Saurabh Prakash, Ryan Toholka
{"title":"Lichen Planus Follicularis Tumidus.","authors":"A I Oloruntoba, Saurabh Prakash, Ryan Toholka","doi":"10.1111/ajd.14545","DOIUrl":"https://doi.org/10.1111/ajd.14545","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144574756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ingrown Toenail With Hypertrophic Skin Bridging. 趾甲向内生长伴增生性皮肤桥接。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-07 DOI: 10.1111/ajd.14563
Karalikkattil T Ashique, Puravoor Jayasree, Feroze Kaliyadan
{"title":"Ingrown Toenail With Hypertrophic Skin Bridging.","authors":"Karalikkattil T Ashique, Puravoor Jayasree, Feroze Kaliyadan","doi":"10.1111/ajd.14563","DOIUrl":"https://doi.org/10.1111/ajd.14563","url":null,"abstract":"<p><p>Onychocryptosis, or ingrown toenail (IGTN), is a painful condition commonly resulting from improper nail trimming or hypertrophic lateral nail folds. We present a rare variant in which the entire distal nail plate becomes embedded within markedly hypertrophic nail folds, forming a tunnel-like structure. This case was successfully managed with radiofrequency excision followed by chemical matricectomy. This combined approach proved highly effective, offering excellent outcomes with minimal complications.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144574755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Dermatologically Aligned Are Territory Doctors? Assessing Dermatology Referrals in Darwin for Diagnostic and Therapeutic Concordance. 地区医生在皮肤病学上是如何一致的?评估皮肤科转诊在达尔文诊断和治疗的一致性。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-05 DOI: 10.1111/ajd.14561
Nicholas Hayes, Christopher Ross, Crystal Williams, Dev Tilakaratne
{"title":"How Dermatologically Aligned Are Territory Doctors? Assessing Dermatology Referrals in Darwin for Diagnostic and Therapeutic Concordance.","authors":"Nicholas Hayes, Christopher Ross, Crystal Williams, Dev Tilakaratne","doi":"10.1111/ajd.14561","DOIUrl":"https://doi.org/10.1111/ajd.14561","url":null,"abstract":"<p><strong>Background/objectives: </strong>A significant number of dermatological presentations in Australia are managed by general practitioners and non-dermatologist health professionals. This audit examines the agreement between referring physicians and dermatologists in a tropical regional setting to identify opportunities for collaborative education and support.</p><p><strong>Methods: </strong>A retrospective audit was conducted at a privately billing dermatology practice in Darwin, Northern Territory of the referrals for 479 patients from January to March 2022. Particular attention was given to the concordance in diagnoses and treatments initiated. A subset of 131 referrals focused on skin cancer surveillance.</p><p><strong>Results: </strong>Only a third of skin cancer referrals included a provisional diagnosis, but, where provided, this corresponded with the dermatologists' assessments 62% of the time. There was 100% diagnostic concordance for presentations of melasma, molluscum/verruca and hidradenitis suppurativa. For acne, hyperhidrosis, and vitiligo, concordance rates ranged from 72.7%-93%. However, treatment concordance was low across all non-skin cancer conditions, with no treatment prescribed by the referring practitioner for more than one quarter of all patients.</p><p><strong>Conclusions: </strong>This audit identified deficiencies in the diagnosis of skin cancer and the management of other dermatological conditions, indicating opportunities for interprofessional collaboration with targeted education to enhance the management and treatment outcomes of dermatological conditions in the Northern Territory.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of Allergic Contact Dermatitis With the New Zealand Baseline Series. 新西兰基线系列诊断过敏性接触性皮炎。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-07-02 DOI: 10.1111/ajd.14555
Aysha Wilson, Harriet Kennedy
{"title":"Diagnosis of Allergic Contact Dermatitis With the New Zealand Baseline Series.","authors":"Aysha Wilson, Harriet Kennedy","doi":"10.1111/ajd.14555","DOIUrl":"https://doi.org/10.1111/ajd.14555","url":null,"abstract":"<p><strong>Background/objectives: </strong>The New Zealand Baseline Series (NZBS) was developed in 2021 to ensure local patch testing was relevant to the population of New Zealand (NZ). It consists of 30 Core allergens and 30 Extended allergens. The aim of this study was to assess performance of the NZBS in diagnosing allergic contact dermatitis (ACD).</p><p><strong>Methods: </strong>A retrospective review was performed of patients patch tested between February 2022 and December 2023, at a public tertiary dermatology clinic and at a private dermatology clinic in Auckland, NZ. Patient demographics and the positivity rate of each allergen were recorded. Performance of the NZBS in diagnosing ACD was categorised as full detection (all relevant allergens identified), partial detection (some, but not all, relevant allergens identified) and no detection (no relevant allergens identified).</p><p><strong>Results: </strong>In total, 209 patients were included in data analysis; 94 from the public clinic and 115 from the private clinic. In total, 105 patients (50%) were diagnosed with ACD with at least one relevant reaction on patch testing. Of those diagnosed with ACD, testing against the NZBS (60 allergens) had a full detection rate of 66%, partial detection in 21% and no detection in 13%.</p><p><strong>Conclusions: </strong>Patch testing with the NZBS has a good detection rate for diagnosing ACD. However, detection of all relevant allergens requires supplementation with additional series and patients' own products. Regular updates to the series are required to improve diagnostic value in the population. We suggest combining study results, literature review and expert consensus to identify emerging or missed allergens not currently captured by the NZBS.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144537946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of the SUNTRAC Tool in Predicting Skin Cancers in Renal Transplant Patients. SUNTRAC工具在肾移植患者皮肤癌预测中的应用。
IF 2.2 4区 医学
Australasian Journal of Dermatology Pub Date : 2025-06-30 DOI: 10.1111/ajd.14558
Sarah Seol, Samuel Reddish, Amanda Oakley
{"title":"The Utility of the SUNTRAC Tool in Predicting Skin Cancers in Renal Transplant Patients.","authors":"Sarah Seol, Samuel Reddish, Amanda Oakley","doi":"10.1111/ajd.14558","DOIUrl":"https://doi.org/10.1111/ajd.14558","url":null,"abstract":"<p><p>This study evaluates the SUNTRAC tool in guiding initial skin cancer risk stratification among renal transplant patients in New Zealand. Higher retrospectively applied SUNTRAC grades in 219 patients were associated with higher incidence of skin cancer, supporting the tool's effectiveness in guiding initial skin cancer risk stratification in this population.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信